THE WIRE
What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Key
BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing
Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.
- GMHSGamehaus Holdings IncPassive stake of 5% or more (13G), filed by Shanghai Jintou Network Technology Co.+18.0%13G ↗
- TMDXTransMedics Group, IncA director sold $385K of stock.$385K−7.3%Form 4 ↗
- WYWeyerhaeuser CoRegulation FD disclosure.−4.3%8-K 7.01 ↗
- MRLNMerlin, IncResults of operations.
Merlin, Inc. Reports Third Quarter 2026 Results Ended Third Quarter 2026 With $161.6 Million in Cash, Cash Equivalents, and Short Term Investments, and No Debt
−17.0%8-K 2.02 ↗ - LYELLyell Immunopharma, IncThe President and CEO sold $9K of stock.$9K−11.8%Form 4 ↗
- LYELLyell Immunopharma, IncThe VP, Corporate Controller sold $7K of stock.$7K−11.8%Form 4 ↗
- LUCKLucky Strike Entertainment CorpA director bought $39K of stock.$39K+26.9%Form 4 ↗
- ITTItt IncThe Vice President & CAO sold $107K of stock.$107K−6.3%Form 4 ↗
- NTLAIntellia Therapeutics, IncResults of operations.−5.2%8-K 2.02 ↗
- TACTTransact Technologies IncResults of operations.−7.4%8-K 2.02 ↗
- TEVATeva Pharmaceutical Industries LTD2 officers sold $12.5M of stock, $10.6M of it under plans set in advance.$12.5M−10.1%
- TEVATeva Pharmaceutical Industries LTDThe President and CEO sold $10.6M of stock under a 10b5-1 plan.$10.6M−10.1%Form 4 ↗
- TEVATeva Pharmaceutical Industries LTDAn officer sold $2.0M of stock.$2.0M−10.1%Form 4 ↗
- CSTLCastle Biosciences IncThe Chief Commercial Officer sold $207K of stock under a 10b5-1 plan.$207K−4.8%Form 4 ↗
- OPCHOption Care Health, IncA director sold $205K of stock.$205K−0.3%Form 4 ↗
- SERSerina Therapeutics, IncResults of operations.
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates - Independent Safety Monitoring Committee recommended advancement of SER-252 in Parkinson's disease to…
−20.6%8-K 2.02 ↗ - SLXNSilexion Therapeutics CorpBylaws or fiscal year changed and other events.−50.8%8-K 3.03 ↗
- EMNEastman Chemical CoMaterial agreement and other events.−10.4%8-K 1.01 ↗
- AFCGAdvanced Flower Capital IncA director bought $101K of stock.$101K−2.4%Form 4 ↗
- ARIApollo Commercial Real Estate Finance Liquidating TrustMaterial agreement and other events.
APOLLO COMMERCIAL REAL ESTATE FINANCE, INC. TRANSFERS REMAINING ASSETS AND LIABILITIES TO APOLLO COMMERCIAL REAL ESTATE FINANCE LIQUIDATING TRUST
0.0%8-K 1.01 ↗ - SSTISoundthinking, IncResults of operations.
SoundThinking, Inc. Reports Third Quarter 2026 Financial Results
−0.1%8-K 2.02 ↗ - MSIMotorola Solutions, IncThe SVP, COS to the Chairman & CEO sold $2.2M of stock.$2.2M−1.9%Form 4 ↗
- MSIMotorola Solutions, IncThe EVP and CTO sold $1.5M of stock.$1.5M−1.9%Form 4 ↗
- MSIMotorola Solutions, IncThe SVP, Human Resources sold $572K of stock.$572K−1.9%Form 4 ↗
- OFRMOnce Upon a Farm, PBCResults of operations.
Once Upon a Farm Reports Third Quarter 2026 Financial Results Third quarter net sales increased 35% year-over-year to $89 million Updating 2026 net sales and adjusted EBITDA outlook
+19.5%8-K 2.02 ↗ - LCIILci IndustriesOther events.
LCI INDUSTRIES DECLARES QUARTERLY CASH DIVIDEND
+1.8%8-K 8.01 ↗ - SRTSSensus Healthcare, IncResults of operations.−29.8%8-K 2.02 ↗
- UEICUniversal Electronics IncA director sold $581K of stock.$581K−17.8%Form 4 ↗
- BOLTBolt Biotherapeutics, IncResults of operations.−16.9%8-K 2.02 ↗
- BCDABioCardia, IncResults of operations.
BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results
−5.0%8-K 2.02 ↗ - ROCRank One Computing CorpFinancial statements and exhibits (amended).−1.4%8-K/A 9.01 ↗
- MGNXMacrogenics IncResults of operations.−14.4%8-K 2.02 ↗
- OUSTOuster, IncA director sold $283K of stock.$283K−35.0%Form 4 ↗
- FDMT4D Molecular Therapeutics, IncResults of operations.−15.6%8-K 2.02 ↗
- PLRXPliant Therapeutics, IncResults of operations.
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results FORTIFY, a Phase 1b indication expansion trial of PLN-101095, continues strong enrollment Pliant’s…
−19.6%8-K 2.02 ↗ - DTILPrecision Biosciences IncThe Chief Legal Officer sold $28K of stock under a 10b5-1 plan.$28K−8.0%Form 4 ↗
- ALMSAlumis IncResults of operations.−35.4%8-K 2.02 ↗
- CBUSCibus, IncResults of operations.+11.0%8-K 2.02 ↗
- CVXChevron CorpThe Vice Chairman sold $23.6M of stock.$23.6M−2.9%Form 4 ↗
- INVEINVE Technologies, IncResults of operations.
INVE Technologies, Inc. Reports Third Quarter 2026 Financial Results Focused on Providing Physical AI Solutions Through Targeted Acquisitions of Enterprise SaaS Companies Signed Strategic…
−18.0%8-K 2.02 ↗ - ONOn Semiconductor CorpMaterial agreement and new debt or obligation.−17.5%8-K 1.01 ↗
- LILAKLiberty Latin America LtdA director bought $5.1M of stock.$5.1M−6.2%Form 4 ↗
- LFMDLifeMD, IncMaterial agreement and results of operations.
Expecting fourth quarter 2026 revenue of between $46 million and $49 million, and Adjusted EBITDA of between negative $4 million to negative $2 million. Conference call begins at 4:30 p.m. Eastern…
−12.7%8-K 1.01 ↗ - OPHCOptimumBank Holdings, IncResults of operations and Regulation FD disclosure.
OptimumBank Holdings, Inc. Financial Performance for the Third Quarter of 2026
−10.4%8-K 2.02 ↗ - RLMDRelmada Therapeutics, IncResults of operations and Regulation FD disclosure.−37.0%8-K 2.02 ↗
- FULCFulcrum Therapeutics, IncOther events.+0.3%8-K 8.01 ↗
- UAMYUnited States Antimony CorpResults of operations.
Significant Liquidity Equal to Year-end 2025 of ~ $90 Million Including Marketable Securities "The Critical Minerals and ZEO Company" ~ Antimony, Gold, Tungsten, and Zeolite ~ DALLAS, TX /
−23.4%8-K 2.02 ↗ - FLNTFluent, IncResults of operations.
Continue to expect full-year double-digit revenue growth on aggregate continuing business and adjusted EBITDA improvement for 2026
+12.2%8-K 2.02 ↗ - PEWGrabAGun Digital Holdings IncResults of operations.
GrabAGun Digital Holdings Reports Third Quarter 2026 Results Gross Profit Increases 44% and Gross Margin Expands 480 Basis Points to 14.4% Third Quarter Net Revenues Were $21.2 Million, a Decrease…
−28.2%8-K 2.02 ↗ - SMTISanara MedTech IncResults of operations.
Sanara MedTech Inc. Reports Third Quarter 2026 Financial Results (Unaudited)
0.0%8-K 2.02 ↗ - SNALSnail, IncResults of operations.
Snail, Inc. Reports Third Quarter 2026 Financial Results
+0.4%8-K 2.02 ↗